Journal of Magnetic Resonance Imaging · 1994 · 40 citations · 17 references
MedicineRadiologyBiomedical ImagingDiagnostic ImagingDiagnostic RadiologyContrast AgentsContrast MediaLiver ImagingMagnetic Resonance ImagingMagnetic Resonance Imaging PhysicsMedical ImagingContrast Agent AdministrationFocal Liver Lesion EvaluationFocal Liver LesionsLiver Lesion DetectionSuperparamagnetic Contrast Agents
AMI-25 was evaluated at 1.5 T as a superparamagnetic iron oxide contrast agent for the liver. Sixteen patients with up to five suspected focal liver lesions were examined with T1-, proton-density-, and T2-weighted spin-echo sequences before and after intravenous administration of AMI-25 (15 mumol/kg iron). The contrast-to-noise ratio (C/N) increased from 1.8 to 3.5 on 600/15 (TR msec/TE msec) images and from 1.7 to 7.9 on 2,500/15 images after AMI-25 administration (P < .01). C/N did not change significantly on 2,500/90 images. Two blinded readers counted the number of lesions visible on unenhanced and contrast-enhanced images, with the 32 sets of images of the 16 patients presented in random order. Both readers identified more lesions on AMI-25-enhanced images, but the difference was not statistically significant (P > .05). Two patients reported minor side effects (flushing, sensation of heat, lower back pain). On the basis of the results obtained in a limited number of patients, the authors conclude that at 1.5 T, AMI-25 does not significantly improve the detection of focal liver lesions on conventional spin-echo images.
17
Book of Abstracts, Society of Magnetic Resonance in Medicine
Jukka I. Tanttu, Raimo Sepponen · 1993 · 394 citations
Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.
Sanjay Saini, D D Stark, Peter F. Hahn et al. · Radiology · 1987 · 229 citations
The Pharmacological Basis of Therapeutics.
Stanley Fahn · Archives of Neurology · 1966 · 192 citations